General Information |
|
Product |
LILRB3 Peptide |
Description |
Antigenic Blocking Peptide Leukocyte immunoglobulin-like receptor subfamily B member 3 precursor Antibody |
Verified Applications |
Immunodepletion, Immunocompetition |
Peptide Description |
Synthetic peptide taken within amino acid region 580-631 on human LILRB3 protein. |
Accession # |
NCBI: NP_001074919.2 |
|
|
Quantity |
250 µg |
Volume |
100 µl |
Form |
Antigenic Blocking Peptide |
Storage |
-20⁰C for long term storage |
|
|
Competition/Depletion assay |
|
|
|
Uniprot # |
|
Overview |
May act as receptor for class I MHC antigens. Becomes activated upon coligation of LILRB3 and immune receptors, such as FCGR2B and the B-cell receptor. Down-regulates antigen-induced B-cell activation by recruiting phosphatases to its immunoreceptor tyrosine-based inhibitor motifs (ITIM). |
Molecular Function |
Receptor, Receptor activity, transmembrane signaling receptor activity |
Subcellular Location |
Cell membrane; Single-pass type I membrane protein |
Expression |
Detected in monocytes and B-cells |
Alternative Nomenclature |
CD85 antigen like family member A antibody HL9 antibody IL T5 antibody Immunoglobulin like transcript 5 antibody LIR 3 antibody MGC138403 antibody Monocyte inhibitory receptor HL9 antibody PIRB antibody |
Protein information supplied by UniProt
Product | Note | Status | Price | |
---|---|---|---|---|
|
LILRB3-312AP | |||
|
LILRB3.2-FITC | |||
|
LILRB3.2-BIOTIN | |||
|
PC-LILRB3 | |||
Display accessory details |
Select your currency:
(c) FabGennix International Inc.